Survey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid Prescriptions
NCT ID: NCT03989128
Last Updated: 2020-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2019-04-23
2021-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer
NCT00900835
Ambulatory Cancer Pain Management: A Feasibility Study
NCT00507351
Development of an Intervention to Enhance Cancer Pain Management
NCT03752268
Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic
NCT03043378
Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center
NCT05095948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To evaluate patients' perceptions of overall difficulties when filling their opioid prescription.
SECONDARY OBJECTIVES:
I. To determine cancer patients' perceptions of financial, logistical, and psychosocial difficulties when filling their opioid prescription.
II. To evaluate the association between patient characteristics and patient difficulty filling opioid prescriptions.
OUTLINE:
Participants complete a survey over 5-10 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational (survey)
Participants complete a survey over 5-10 minutes
Medical Chart Review
Undergo medical chart review
Survey Administration
Complete survey
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical Chart Review
Undergo medical chart review
Survey Administration
Complete survey
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must be able to understand, read, write, and speak English.
* Patients must sign an informed consent document.
* Patients must have a cancer diagnosis.
Exclusion Criteria
* Patients who are considered to be in severe physical or emotional distress based on the assessment by the research staff.
* Patients who refuse to participate in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eduardo Bruera
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2019-02912
Identifier Type: REGISTRY
Identifier Source: secondary_id
2019-0052
Identifier Type: OTHER
Identifier Source: secondary_id
2019-0052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.